Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Precursor-to-product ratios reflect biochemical phenotype in congenital adrenal hyperplasia.

Hicks RA, Yee JK, Mao CS, Graham S, Kharrazi M, Lorey F, Lee WP.

Metabolomics. 2014 Feb 1;10(1):123-131.

PMID:
24489528
[PubMed]
2.

Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry.

Lacey JM, Minutti CZ, Magera MJ, Tauscher AL, Casetta B, McCann M, Lymp J, Hahn SH, Rinaldo P, Matern D.

Clin Chem. 2004 Mar;50(3):621-5. Epub 2003 Dec 4.

PMID:
14656905
[PubMed - indexed for MEDLINE]
Free Article
3.

Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.

Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J.

J Clin Endocrinol Metab. 2007 Jul;92(7):2581-9. Epub 2007 Apr 24.

PMID:
17456574
[PubMed - indexed for MEDLINE]
4.

False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.

Fingerhut R.

Steroids. 2009 Aug;74(8):662-5. doi: 10.1016/j.steroids.2009.02.008. Epub 2009 Mar 9.

PMID:
19463687
[PubMed - indexed for MEDLINE]
5.

Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.

Mitchell ML, Hermos RJ.

Clin Endocrinol (Oxf). 1998 Jun;48(6):757-60.

PMID:
9713565
[PubMed - indexed for MEDLINE]
6.

Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry.

Magnisali P, Chalioti MB, Livadara T, Mataragas M, Paliatsiou S, Malamitsi-Puchner A, Moutsatsou P.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jun 1;879(19):1565-72. doi: 10.1016/j.jchromb.2011.03.048. Epub 2011 Apr 4.

PMID:
21514253
[PubMed - indexed for MEDLINE]
7.

Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.

Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A.

J Pediatr. 1997 Jan;130(1):128-33.

PMID:
9003862
[PubMed - indexed for MEDLINE]
9.

Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.

Janzen N, Riepe FG, Peter M, Sander S, Steuerwald U, Korsch E, Krull F, Müller HL, Heger S, Brack C, Sander J.

Horm Res Paediatr. 2012;77(3):195-9. doi: 10.1159/000337974. Epub 2012 Apr 13.

PMID:
22508345
[PubMed - indexed for MEDLINE]
10.

Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.

Seo JY, Park HD, Kim JW, Oh HJ, Yang JS, Chang YS, Park WS, Lee SY.

J Perinat Med. 2014 Jan;42(1):121-7. doi: 10.1515/jpm-2013-0154.

PMID:
23989111
[PubMed - in process]
11.

An automated method on analysis of blood steroids using liquid chromatography tandem mass spectrometry: application to population screening for congenital adrenal hyperplasia in newborns.

Dhillon K, Ho T, Rich P, Xu D, Lorey F, She J, Bhandal A.

Clin Chim Acta. 2011 Nov 20;412(23-24):2076-84. doi: 10.1016/j.cca.2011.07.009. Epub 2011 Jul 23.

PMID:
21803033
[PubMed - indexed for MEDLINE]
13.

[Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 1. Enzyme immunoassay of dried blood 17 alpha-hydroxyprogesterone and its application to neonatal screening for congenital adrenal hyperplasia].

Fukushi M, Arai O, Mizushima Y, Takasugi N, Fujieda K, Matsuura N.

Nihon Naibunpi Gakkai Zasshi. 1986 Jun 20;62(6):683-96. Japanese.

PMID:
3530828
[PubMed - indexed for MEDLINE]
14.

Combined 21- and 11 beta-hydroxylase deficiency in familial congenital adrenal hyperplasia.

Hurwitz A, Brautbar C, Milwidsky A, Vecsei P, Milewicz A, Navot D, Rösler A.

J Clin Endocrinol Metab. 1985 Apr;60(4):631-8.

PMID:
2982904
[PubMed - indexed for MEDLINE]
15.

Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.

Schreiner F, Tozakidou M, Maslak R, Holtkamp U, Peter M, Gohlke B, Woelfle J.

Eur J Endocrinol. 2009 Apr;160(4):667-73. doi: 10.1530/EJE-08-0639. Epub 2009 Jan 27.

PMID:
19174530
[PubMed - indexed for MEDLINE]
Free Article
16.

A contribution to the classification of cases of non-classic 21-hydroxylase-deficient congenital adrenal hyperplasia.

Phocas I, Chryssikopoulos A, Sarandakou A, Rizos D, Trakakis E.

Gynecol Endocrinol. 1995 Sep;9(3):229-38.

PMID:
8540293
[PubMed - indexed for MEDLINE]
17.

Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.

Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F; Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group.

Eur J Endocrinol. 2005 Jun;152(6):869-74.

PMID:
15941926
[PubMed - indexed for MEDLINE]
Free Article
18.

[A method for the quantitative analysis of steroid hormones by HPLC/RIA].

Ueshiba H.

Nihon Naibunpi Gakkai Zasshi. 1987 Jun 20;63(6):809-22. Japanese.

PMID:
3666243
[PubMed - indexed for MEDLINE]
19.

[Congenital adrenal hyperplasia].

Stanić M, Nesović M.

Med Pregl. 1999 Nov-Dec;52(11-12):447-54. Review. Croatian.

PMID:
10748766
[PubMed - indexed for MEDLINE]
20.

Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.

Lee JE, Moon Y, Lee MH, Jun YH, Oh KI, Choi JW.

Ann Clin Lab Sci. 2008 Summer;38(3):235-40.

PMID:
18715851
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk